China Universal Asset Management Co., Ltd. G1 Therapeutics, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 21, 2024	BUY	$1.22 - $2.67 $797 - $1,746	654 Added 96.6%	1,331 $1,000
Q3 2023 Oct 30, 2023	BUY	$1.22 - $2.67 $797 - $1,746	654 Added 96.6%	1,331 $2,000
Q2 2023 May 21, 2024	SELL	$2.46 - $3.14 $22 - $28	-9 Reduced 1.31%	677 $1,000
Q2 2023 Jul 27, 2023	SELL	$2.46 - $3.14 $22 - $28	-9 Reduced 1.31%	677 $2,000
Q1 2023 May 21, 2024	BUY	$2.57 - $8.16 $442 - $1,403	172 Added 33.46%	686 $1,000
Q1 2023 Apr 27, 2023	BUY	$2.57 - $8.16 $442 - $1,403	172 Added 33.46%	686 $2,000
Q4 2022 May 21, 2024	BUY	$5.19 - $13.5 $2,667 - $6,939	514 New	514 $2,000
Q4 2022 Jan 31, 2023	BUY	$5.19 - $13.5 $586 - $1,525	113 Added 28.18%	514 $3,000
Q3 2022 Oct 21, 2022	BUY	$5.17 - $16.99 $2,073 - $6,812	401 New	401 $5,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account